Conavi Showcases Clinical Imaging Evidence
TORONTO, July 8, 2026 Conavi Medical Corp. announced the publication of a clinical case report in the Journal of...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
TORONTO, July 8, 2026 Conavi Medical Corp. announced the publication of a clinical case report in the Journal of...
MELBOURNE, Australia, June 29, 2026 4DMedical has achieved a major regulatory milestone with the Therapeutic Goods Administration (TGA) approving...
SOMERSET, N.J., June 29, 2026 Terumo Interventional Systems (TIS), a division of Terumo Corporation, has announced the successful completion...
ATLANTA, Ga., June 29, 2026 Artivion, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted...
ZUG, Switzerland, May 20, 2026 Implantica AG announced that it has submitted its final response to the U.S. Food...
AMSTERDAM, Netherlands, May 18, 2026 Royal Philips has introduced SmartIQ, a breakthrough AI-enabled coronary imaging technology developed for its...
